Literature DB >> 3627286

Ketoconazole impairs biliary excretory function in the isolated perfused rat liver.

G B Gaeta, M F Tripodi.   

Abstract

The effects of ketoconazole (KT) on the hepatic excretory function was investigated in the isolated perfused rat liver. KT, at the concentrations of 5 X 10(-5) M or 10(-4) M caused dose-dependent decreases of the biliary bile acid concentration and excretion rate, with no significant effect on bile flow rates. Neither dose altered perfusate flow through the liver. Furthermore, at the same two concentrations, KT impaired the sulfobromophthalein transport in a dose-dependent manner. In contrast, the drug did not alter 14C-sucrose bile to perfusate ratio and did not cause enzyme release from the liver into the perfusate. The study demonstrates that KT possesses an intrinsic toxicity in the isolated perfused rat liver and suggests caution in the use of this drug in hepatopathic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3627286     DOI: 10.1007/BF00166989

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  INITIAL DISTRIBUTION AND RATE OF UPTAKE OF SULFOBROMOPHTHALEIN IN THE LIVER.

Authors:  C A GORESKY
Journal:  Am J Physiol       Date:  1964-07

2.  Principles of the enzymatic measurement of steroids.

Authors:  B HURLOCK; P TALALAY
Journal:  J Biol Chem       Date:  1957-07       Impact factor: 5.157

3.  Rate of release of cytoplasmic and mitochondrial enzymes from the isolated and perfused rat liver treated with phalloidin.

Authors:  G Ruggiero
Journal:  J Lab Clin Med       Date:  1973-11

4.  Hepatic reactions during ketoconazole treatment.

Authors:  P A Janssen; J E Symoens
Journal:  Am J Med       Date:  1983-01-24       Impact factor: 4.965

5.  Toxic hepatis during ketoconazole treatment.

Authors:  J K Heiberg; E Svejgaard
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

6.  An evaluation of two years of clinical experience with ketoconazole.

Authors:  J Symoens; M Moens; J Dom; H Scheijgrond; J Dony; V Schuermans; R Legendre; N Finestine
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

7.  Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.

Authors:  E A Petersen; D W Alling; C H Kirkpatrick
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

8.  Cholestatic effects of Escherichia coli endotoxin endotoxin on the isolated perfused rat liver.

Authors:  R Utili; C O Abernathy; H J Zimmerman
Journal:  Gastroenterology       Date:  1976-02       Impact factor: 22.682

9.  Biliary secretion of fluid-phase markers by the isolated perfused rat liver. Role of transcellular vesicular transport.

Authors:  J R Lake; V Licko; R W Van Dyke; B F Scharschmidt
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver.

Authors:  G B Gaeta; R Utili; L E Adinolfi; C O Abernathy; G Giusti
Journal:  Toxicol Appl Pharmacol       Date:  1985-09-15       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.